{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:12:59Z","timestamp":1779300779826,"version":"3.51.4"},"reference-count":74,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"21","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 LM010098"],"award-info":[{"award-number":["R01 LM010098"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["EP\/S021612\/1"],"award-info":[{"award-number":["EP\/S021612\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["EP\/Z000211\/1"],"award-info":[{"award-number":["EP\/Z000211\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/18\/5033837, PG\/22\/10989"],"award-info":[{"award-number":["PG\/18\/5033837, PG\/22\/10989"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["AA\/18\/6\/34223"],"award-info":[{"award-number":["AA\/18\/6\/34223"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["M202-F2"],"award-info":[{"award-number":["M202-F2"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["CF-2023-M-2\\122"],"award-info":[{"award-number":["CF-2023-M-2\\122"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UKRI\/NIHR Multimorbidity Fund Mechanism and Therapeutics Research Collaborative","award":["MR\/V033867\/1"],"award-info":[{"award-number":["MR\/V033867\/1"]}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/24\/130013"],"award-info":[{"award-number":["RE\/24\/130013"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCL NIHR Biomedical Research Centre"}],"content-domain":{"domain":["www.science.org"],"crossmark-restriction":true},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2026,5,22]]},"abstract":"<jats:p>Multimorbidity presents challenges for research and health care. We investigated how immune-proteins influence multiple diseases to identify shared mechanisms and therapeutic opportunities. Using eight large plasma proteome GWAS, we identified cis-acting variants for 151 immune-proteins and applied cis-Mendelian randomization to assess associations with 64 diseases and biomarkers. Protein-disease communities were derived using a knowledge graph integrating multiplicity-corrected associations, druggability, indications, and tissue-trait associations. Replication was sought in independent pQTLs, with colocalization applied to replicated signals. Immune-proteins were frequently implicated in coronary heart disease, venous thromboembolism, atrial fibrillation, type 2 diabetes, and Parkinson\u2019s disease. Seven protein communities mapped to pathways including ficolin binding and antimicrobial peptides, enriched for proteins influencing multiple diseases. Several associations replicated with colocalization support, including APOE, CD163, and IL-6R across neurodegenerative, cardiometabolic, and inflammatory traits. We found strong genetic support for druggable immune-proteins with pleiotropic effects across common diseases, highlighting opportunities for indication expansion and therapeutic development.<\/jats:p>","DOI":"10.1126\/sciadv.adz7117","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:00:40Z","timestamp":1779300040000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark","source":"Crossref","is-referenced-by-count":0,"title":["The immunoproteome and multimorbidity: A Mendelian randomization study"],"prefix":"10.1126","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3505-3586","authenticated-orcid":true,"given":"Nikita","family":"Hukerikar","sequence":"first","affiliation":[{"name":"Institute of Health Informatics, Faculty of Population Health Sciences, University College London, 222 Euston Road, London NW1 2DA, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-0081","authenticated-orcid":true,"given":"Aroon D.","family":"Hingorani","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, Faculty of Population Health, University College London, 69-75 Chenies Mews, London WC1E 6HX, UK."},{"name":"UCL British Heart Foundation Centre of Excellence, 69-75 Chenies Mews, London WC1E 6HX, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandesh","family":"Chopade","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, Faculty of Population Health, University College London, 69-75 Chenies Mews, London WC1E 6HX, UK."},{"name":"UCL British Heart Foundation Centre of Excellence, 69-75 Chenies Mews, London WC1E 6HX, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3300-8124","authenticated-orcid":true,"given":"Arjen J.","family":"Cupido","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam UMC, locatie AMC Postbus 22660, 1100 DD Amsterdam-Zuidoost, Netherlands."},{"name":"Department of Internal Medicine, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam UMC, locatie AMC Postbus 22660, 1100 DD Amsterdam-Zuidoost, Netherlands."},{"name":"Department of Internal Medicine, Tergooi MC, Laan van Tergooi 2, 1212 VG Hilversum, Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1692-8669","authenticated-orcid":true,"given":"Folkert W.","family":"Asselbergs","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics, Faculty of Population Health Sciences, University College London, 222 Euston Road, London NW1 2DA, UK."},{"name":"Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam UMC, locatie AMC Postbus 22660, 1100 DD Amsterdam-Zuidoost, Netherlands."},{"name":"National Institute for Health Research University College London Hospitals Biomedical Research Centre, UCLH\/UCL Joint Research Office, 250 Euston Road, London NW1 2PG, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3319-1937","authenticated-orcid":true,"given":"Chris","family":"Finan","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics, Faculty of Population Health Sciences, University College London, 222 Euston Road, London NW1 2DA, UK."},{"name":"Institute of Cardiovascular Science, Faculty of Population Health, University College London, 69-75 Chenies Mews, London WC1E 6HX, UK."},{"name":"UCL British Heart Foundation Centre of Excellence, 69-75 Chenies Mews, London WC1E 6HX, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Floriaan","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, Faculty of Population Health, University College London, 69-75 Chenies Mews, London WC1E 6HX, UK."},{"name":"UCL British Heart Foundation Centre of Excellence, 69-75 Chenies Mews, London WC1E 6HX, UK."},{"name":"Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam UMC, locatie AMC Postbus 22660, 1100 DD Amsterdam-Zuidoost, Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02420-6"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(22)00187-X"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54849-w"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.117462"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2011.10.004"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.230"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs354"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60110-X"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00921-z"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","unstructured":"K. M. Fulton S. M. Twine \u201cImmunoproteomics: Current technology and applications \u201d in Immunoproteomics: Methods and Protocols K. M. Fulton S. M. Twine Eds. (Humana Press 2013) pp. 21\u201357.","DOI":"10.1007\/978-1-62703-589-7_2"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00603-1"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00877-7"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw088"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a039230"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16969-0"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25703-3"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07316-0"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-024-00625-5"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12644"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01363-1"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03496-2"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-379214"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.7150\/thno.50683"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","unstructured":"P. A. Gerlach N. Milind J. P. Spence J. K. Pritchard High false sign rates in transcriptome-wide association studies. bioRxiv 695550 [Preprint] (2025); https:\/\/doi.org\/10.64898\/2025.12.19.695550.","DOI":"10.64898\/2025.12.19.695550"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01583"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020142"},{"key":"e_1_3_2_29_2","unstructured":"H. Communications \u201cZinbryta withdrawn from marketplace \u201d MSAA (2018); https:\/\/mymsaa.org\/news\/zinbryta-withdrawn\/."},{"key":"e_1_3_2_30_2","unstructured":"\u201cDaclizumab withdrawn from NHS after safety concerns \u201d MS Society (2018); www.mssociety.org.uk\/research\/news\/daclizumab-withdrawn-nhs-after-safety-concerns."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-023-01845-6"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13556"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-022-00404-3"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2022.06.003"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93683-1"},{"key":"e_1_3_2_36_2","unstructured":"Zenas BioPharma (USA) LLC \u201cA phase 3 multicenter randomized double-blind placebo-controlled study with an open label safety and dose confirmation run-in period to evaluate the efficacy and safety of obexelimab in patients with warm autoimmune hemolytic anemia (SApHiAre)\u201d (Clinical trial registration NCT05786573 clinicaltrials.gov 2025); https:\/\/clinicaltrials.gov\/study\/NCT05786573."},{"key":"e_1_3_2_37_2","unstructured":"Zenas BioPharma (USA) LLC \u201cA phase 3 multicenter randomized double-blind placebo-controlled study to evaluate the efficacy and safety of obexelimab in patients with IgG4-related disease (INDIGO)\u201d (Clinical trial registration NCT05662241 clinicaltrials.gov 2024); https:\/\/clinicaltrials.gov\/study\/NCT05662241."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.42652"},{"key":"e_1_3_2_39_2","unstructured":"S. Aboobacker H. Kurn A. M. Al Aboud \u201cSecukinumab \u201d in StatPearls (StatPearls Publishing 2025); http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537091\/."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-025-01389-5"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1100"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-022-04706-x"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.22077"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7221"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3034"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay5947"},{"key":"e_1_3_2_50_2","unstructured":"The Human Protein Atlas; www.proteinatlas.org\/."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0810772105"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1080\/02763869.2020.1826228"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq968"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkh061"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1166"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr777"},{"key":"e_1_3_2_57_2","unstructured":"Clinical Trial Research | Trialtrove l Pharma Intelligence; https:\/\/pharmaintelligence.informa.com\/products-and-services\/clinical-planning\/trialtrove."},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg034"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005968"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/iyad031"},{"key":"e_1_3_2_61_2","unstructured":"Neo4j Graph Data Platform\u2013The Leader in Graph Databases Neo4j Graph Data Platform; https:\/\/neo4j.com\/."},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5413.139827"},{"key":"e_1_3_2_63_2","unstructured":"J. Hoppa Graph Algorithms in Neo4j: Louvain Modularity Graph Database & Analytics (2019): https:\/\/neo4j.com\/blog\/graph-algorithms-neo4j-louvain-modularity\/."},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06592-6"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009440"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29650-5"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00978-w"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20079-2"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0175-2"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-00287-2"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-021-00886-6"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05512-x"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2016.11.007"},{"key":"e_1_3_2_75_2","first-page":"205","article-title":"A benchmark of gene expression tissue-specificity metrics","volume":"18","author":"Kryuchkova-Mostacci N.","year":"2017","unstructured":"N. Kryuchkova-Mostacci, M. Robinson-Rechavi, A benchmark of gene expression tissue-specificity metrics. Brief. Bioinform. 18, 205\u2013214 (2017).","journal-title":"Brief. Bioinform."}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.adz7117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:03:00Z","timestamp":1779300180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.adz7117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":74,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,5,22]]}},"alternative-id":["10.1126\/sciadv.adz7117"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.adz7117","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"2025-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"eadz7117"}}